Moderna Reports ‘Robust’ Response From COVID-19 Booster Shots

Pipeline Sees Continued Progress, Helped By Vaccine Windfall

Executives said the company was “capacity constrained” for 2021 and not taking further mRNA-1273 vaccine orders for delivery this year.

Moderna vaccine
Moderna's COVID-19 vaccine provided the company with a huge windfall as it registered a $2.3bn profit • Source: Shutterstock

More from Strategy

More from Business